Web
|
Images
|
News
News Home
US
World
Business
Finance
Industry
Technology
Science
Media & Advertising
Politics/Law
Entertainment
Internet
Health
Sports
Culture
IP AND PATENTS
Log In
Biogen Updates Tysabri Label To Reflect Risk With Longer Use
Have an interest in this Story?
Sign Up for Real-Time email updates
Nasdaq
|
November 06, 2009
NEW YORK -(Dow Jones)- Biogen Idec Inc. (BIIB) amended the U.S. label of multiple sclerosis treatment Tysabri, sold with Elan Corp. PLC (ELN), on Friday to reflect that the risk of a rare brain infection rises with longer usage. The changes, which were expected, note that the occurrence of progressi...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Log in
|
Register
Most Read World Articles
NSW fire breaks containment lines
- Yahoo! News Australia
Re: Health Care Bill Beats Filibuster
- Motley Fool Discussion Boards
Hurriyat: China has stake in S.Asia peace
- Reuters India
Michael Scott remembered at funeral service
- Chicago Tribune
Feeling the heat
- Washington Post
Featured Members
Martin P. Lee
Associate Lecturer
Knowledge Management
Niladri Roy
Manager-International Marketing
Computer Services
View more profiles
Access dozens of premium and subscriptions sites
Free!
Download now
.
Advertise
|
Build a News Circle
|
Get News Briefings
|
Congoo News Home
|
Get the Netpass
About Congoo
|
Terms
|
Privacy
|
Need Help?
|
Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.
